Literature DB >> 6603980

The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.

N C Hughes-Jones, B D Gorick, J C Howard.   

Abstract

The mechanism of synergistic complement-mediated lysis of rat red cells was investigated using rat monoclonal antibodies against class I RT1Aa antigens. The increased lytic activity when using two antibodies simultaneously is due to the increase in the number of activated C1 molecules on the cell surface and this results from (a) an increase in the number of binding sites for C1q, (b) an increase in the functional affinity constant for C1q binding and (c) an increase in the rate of activation of C1. Complete lysis of red cells was only achieved if one member of the synergistic pair was of the gamma 2b isotype, and this isotype was the only one to which binding of 125I-labeled C1q could be detected. A partial synergistic effect was seen using an F(ab')2 fragment of antibody. Increased uptake and activation of C1 probably results both from the presence of two antibodies attached to each antigen molecule and from the formation of antigen-antibody catenars.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603980     DOI: 10.1002/eji.1830130806

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.

Authors:  Christian Rutemark; Elisabeth Alicot; Anna Bergman; Minghe Ma; Andrew Getahun; Stephan Ellmerich; Michael C Carroll; Birgitta Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Immunoglobulin locus associates with serum IgG levels and albuminuria.

Authors:  Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Eric Boerwinkle; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 10.121

4.  Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker.

Authors:  Geng Zhang; Hongtao Zhang; Qiang Wang; Priti Lal; Ann M Carroll; Margarita de la Llera-Moya; Xiaowei Xu; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

5.  Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

6.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

Authors:  C I Bindon; G Hale; M Brüggemann; H Waldmann
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.